Comorbidity significantly affects clinical outcome after cardiac resynchronization therapy regardless of ventricular remodeling

Journal of Cardiac Failure

Volumn 18, Issue 11, 2012, Pages 845-853

  Verbrugge, Frederik H ^a,b   Dupont, Matthias ^a,c   Rivero Ayerza, Maximo ^a   De Vusser, Philippe ^a   Van Herendael, Hugo ^a   Vercammen, Jan ^a   Jacobs, Linda ^a   Verhaert, David ^a,c   Vandervoort, Pieter ^a,b   Tang, W H Wilson ^b   Mullens, Wilfried ^a,b  

^a DEPARTMENT OF CARDIOLOGY   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

adverse events; Biventricular pacing; frailty; treatment response

Indexed keywords

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE; HEART VENTRICLE REMODELING; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARDIAC RESYNCHRONIZATION THERAPY; COHORT STUDIES; COMORBIDITY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 84868566836     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2012.09.003     Document Type: Article

References (39)

1. C. Leclercq, and D.A. Kass Retiming the failing heart: principles and current clinical status of cardiac resynchronization J Am Coll Cardiol 39 2002 194 201
2. C. Linde, C. Leclercq, S. Rex, S. Garrigue, T. Lavergne, and S. Cazeau Long-term benefits of biventricular pacing in congestive heart failure: results from the Multisite Stimulation in Cardiomyopathy (MUSTIC) study J Am Coll Cardiol 40 2002 111 118
3. M.R. Bristow, L.A. Saxon, J. Boehmer, S. Krueger, D.A. Kass, and T. de Marco Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
4. J.G. Cleland, J.C. Daubert, E. Erdmann, N. Freemantle, D. Gras, and L. Kappenberger The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
5. J.G. Cleland, J.C. Daubert, E. Erdmann, N. Freemantle, D. Gras, and L. Kappenberger Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the Cardiac Resynchronization-Heart Failure (CARE-HF) trial extension phase] Eur Heart J 27 2006 1928 1932
6. M. Rivero-Ayerza, D.A. Theuns, H.M. Garcia-Garcia, E. Boersma, M. Simoons, and L.J. Jordaens Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials Eur Heart J 27 2006 2682 2688
7. C. Linde, W.T. Abraham, M.R. Gold, M. St John Sutton, S. Ghio, and C. Daubert Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms J Am Coll Cardiol 52 2008 1834 1843
8. A.J. Moss, W.J. Hall, D.S. Cannom, H. Klein, M.W. Brown, and J.P. Daubert Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 2009 1329 1338
9. A.S. Tang, G.A. Wells, M. Talajic, M.O. Arnold, R. Sheldon, and S. Connolly Cardiac-resynchronization therapy for mild-to-moderate heart failure N Engl J Med 363 2010 2385 2395
10. S. Adabag, H. Roukoz, I.S. Anand, and A.J. Moss Cardiac resynchronization therapy in patients with minimal heart failure: a systematic review and meta-analysis J Am Coll Cardiol 58 2011 935 941
11. D.A. Theuns, B.A. Schaer, O.I. Soliman, D. Altmann, C. Sticherling, and M.L. Geleijnse The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality Europace 13 2011 62 69
12. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen, N.A. Estes 3rd, R.A. Freedman, and L.S. Gettes ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation 117 2008 e350 e408
13. J.J. McMurray, S. Adamopoulos, S.D. Anker, A. Auricchio, M. Bohm, and K. Dickstein ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur J Heart Fail 14 2012 803 869
14. W. Mullens, R.A. Grimm, T. Verga, T. Dresing, R.C. Starling, and B.L. Wilkoff Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program J Am Coll Cardiol 53 2009 765 773
15. W. Mullens, J. Kepa, P. De Vusser, J. Vercammen, M. Rivero-Ayerza, and P. Wagner Importance of adjunctive heart failure optimization immediately after implantation to improve long-term outcomes with cardiac resynchronization therapy Am J Cardiol 108 2011 409 415
16. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, D. Roth Modification of Diet in Renal Disease Study Group A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Ann Intern Med 130 1999 461 470
17. A. Qaseem, T.J. Wilt, S.E. Weinberger, N.A. Hanania, G. Criner, and T. van der Molen Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society Ann Intern Med 155 2011 179 191
18. N.B. Schiller, P.M. Shah, M. Crawford, A. DeMaria, R. Devereux, and H. Feigenbaum Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms J Am Soc Echocardiogr 2 1989 358 367
19. J.P. Singh, J.C. Evans, D. Levy, M.G. Larson, L.A. Freed, and D.L. Fuller Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study) Am J Cardiol 83 1999 897 902
20. R. Bai, L. di Biase, C. Elayi, C.K. Ching, C. Barrett, and K. Philipps Mortality of heart failure patients after cardiac resynchronization therapy: identification of predictors J Cardiovasc Electrophysiol 19 2008 1259 1265
21. R.J. van Bommel, C.J. Borleffs, C. Ypenburg, N.A. Marsan, V. Delgado, and M. Bertini Morbidity and mortality in heart failure patients treated with cardiac resynchronization therapy: influence of pre-implantation characteristics on long-term outcome Eur Heart J 31 2010 2783 2790
22. R.J. van Bommel, S.A. Mollema, C.J. Borleffs, M. Bertini, C. Ypenburg, and N.A. Marsan Impaired renal function is associated with echocardiographic nonresponse and poor prognosis after cardiac resynchronization therapy J Am Coll Cardiol 57 2011 549 555
23. G. Lin, B.J. Gersh, E.L. Greene, M.M. Redfield, D.L. Hayes, and P.A. Brady Renal function and mortality following cardiac resynchronization therapy Eur Heart J 32 2011 184 190
24. D.T. Martin, S. McNitt, R.W. Nesto, M.K. Rutter, and A.J. Moss Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT) Circ Heart Fail 4 2011 332 338
25. S.B. Wilton, A.A. Leung, W.A. Ghali, P. Faris, and D.V. Exner Outcomes of cardiac resynchronization therapy in patients with vs those without atrial fibrillation: a systematic review and meta-analysis Heart Rhythm 8 2011 1088 1094
26. S.B. Wilton, K.M. Kavanagh, S.G. Aggarwal, F. Philippon, R. Yee, and K. Cowan Association of rate-controlled persistent atrial fibrillation with clinical outcome and ventricular remodelling in recipients of cardiac resynchronization therapy Can J Cardiol 27 2011 787 793
27. S. Kirubakaran, A. Ladwiniec, A. Arujuna, M. Ginks, M. McPhail, and J. Bostock Male gender and chronic obstructive pulmonary disease predict a poor clinical response in patients undergoing cardiac resynchronisation therapy Int J Clin Pract 65 2011 281 288
28. H.M. Krumholz, T.E. Seeman, S.S. Merrill, C.F. Mendes de Leon, V. Vaccarino, and D.I. Silverman Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years Jama 272 1994 1335 1340
29. M.C. Corti, J.M. Guralnik, M.E. Salive, T. Harris, L. Ferrucci, and R.J. Glynn Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons Ann Intern Med 126 1997 753 760
30. T.B. Horwich, M.A. Hamilton, W.R. Maclellan, and G.C. Fonarow Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure J Card Fail 8 2002 216 224
31. I. Goldenberg, A.J. Moss, W.J. Hall, E. Foster, J.J. Goldberger, and P. Santucci Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT) Circulation 124 2011 1527 1536
32. J.C. Hsu, S.D. Solomon, M. Bourgoun, S. McNitt, I. Goldenberg, and H. Klein Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) study J Am Coll Cardiol 59 2012 2366 2373
33. A.S. Levey, J. Coresh, T. Greene, L.A. Stevens, Y.L. Zhang, and S. Hendriksen Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate Ann Intern Med 145 2006 247 254
34. W.H. Tang, and W. Mullens Cardiorenal syndrome in decompensated heart failure Heart 96 2010 255 260
35. D.E. Forman, J. Butler, Y. Wang, W.T. Abraham, C.M. O'Connor, and S.S. Gottlieb Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure J Am Coll Cardiol 43 2004 61 67
36. E.S. Chung, A.R. Leon, L. Tavazzi, J.P. Sun, P. Nihoyannopoulos, and J. Merlino Results of the Predictors of Response to CRT (PROSPECT) trial Circulation 117 2008 2608 2616
37. C. Daubert, M.R. Gold, W.T. Abraham, S. Ghio, C. Hassager, and G. Goode Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial J Am Coll Cardiol 54 2009 1837 1846
38. W.T. Abraham, W.G. Fisher, A.L. Smith, D.B. Delurgio, A.R. Leon, and E. Loh Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853
39. J.B. Young, W.T. Abraham, A.L. Smith, A.R. Leon, R. Lieberman, and B. Wilkoff Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial Jama 289 2003 2685 2694